Interleukin-6 (IL-6) is a growth factor for multiple myeloma and downregulated by IL-6; again, IL-6 inhibited the increase in p21 triggered by Dex. These alterations in p21 expression (MM) cells and can inhibit MM cell apoptosis. Our recent studies show that IL-6 facilitates MM cell growth via phos-in MM cells were associated with changes in p21 binding to CDK2, CDK4, and CDK6; CDK2, CDK4, and CDK6 kinase phorylation of retinoblastoma protein (pRB); however, the effects of IL-6 on those cyclins, cyclin-dependent kinases activities; and phosphorylation of pRB. In contrast, expression of G1 cell cycle regulatory proteins, including p27KIP1, (CDKs), and CDK inhibitors (CDIs) that are known to regulate phosphorylation of pRB have not been defined in MM cells. cyclin D2, and cyclin E, was not altered in MM cells cultured with Dex and/or IL-6. Finally, interferon-g (IFN-g) also in-In the present report, we cultured MM cell lines and patient cells with IL-6 and/or dexamethasone (Dex) and character-duced G1 growth arrest and upregulated p21 protein expression; as with Dex, affects of IFN-g were inhibited by IL-6. ized changes in cell cycle; expression and association of cyclins, CDKs, and CDIs; and phosphorylation of pRB. Dex
G cycle control in MM cells is not yet defined.
ROWTH AND differentiation of normal and malignant cells can be regulated by a variety of external stimuli,
In the present report, we investigated the effects of IL-6, ie, cytokines or cell-cell and cell-extracellular matrix interac-Dex, or both on cyclins, CDKs, and CDIs affecting phostions. The same growth factor may have differential effects phorylation of pRB in both MM-derived cell lines and patient on normal and malignant cells. For example, interleukin-6 MM cells. Dex induced G1 growth arrest in MM cells, an (IL-6) is a differentiation factor for normal B cells but is an effect that was inhibited by IL-6. Dex upregulated and ILautocrine and paracrine growth factor, as well as an anti-6 downregulated p21WAF1 (p21) expression in MM cells apoptotic factor, for multiple myeloma (MM) cells. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] IL- in a time-and dose-dependent fashion, and IL-6 prevented 1b, tumor necrosis factor-a, transforming growth factor b, this p21 upregulation. Changes in p21 expression in MM interferons (IFNs), CD40 ligand, dexamethasone (Dex), reticells were associated with changes in its binding to CDK2, noic acid, and adhesion to bone marrow (BM) stromal cells CDK4, and CDK6; CDK2, CDK4, and CDK6 kinase activialso effect MM cell growth and survival, and many of these ties; phosphorylation of pRB; and cell cycle progression. As stimuli either modulate production of IL-6 or expression of with Dex, IFN-g induced G1 growth arrest and decreased IL-6 receptor (IL-6R) on tumor cells. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] For example, Dex p21 expression in MM cells; IL-6 similarly inhibited these inhibits proliferation and induces apoptosis of MM cells; it IFN-g-related effects. Our results therefore show that can induce apoptosis of MM cells growing in an IL-6-medichanges in cell cycle distribution triggered by Dex, IL-6, ated autocrine mechanism by both blocking IL-6 production and IFN-g are correlated with changes in p21 protein expresand by inhibiting IL-6R expression on tumor cells. 9 Dex can sion in MM cells. also induce growth arrest and apoptosis in MM cells that grow independently of IL-6; however, even in this setting, MATERIALS AND METHODS IL-6 can inhibit Dex-related affects. 23 Finally, IFN represents Preparation of cells. Mononuclear cells (MCs) were isolated another example of therapy for MM that may, at least in part, from five patients with MM by Ficoll-Hypaque (FH) density gradient work by downregulating IL-6R expression on MM cells. [14] [15] [16] [17] centrifugation and then incubated with HB7 (anti-CD38) monoclonal Delineation of the molecular targets whereby these external antibody (MoAb)-biotin-streptavidin and 2H4 (anti-CD45RA) stimuli regulate MM cell growth and survival might not only MoAb-fluorescein isothiocyanate on ice. Tumor cells (ú95% enhance our understanding of disease pathogenesis, but also both elucidate the mechanisms of current treatments and suggest novel therapies. and T cells were next depleted by double adherence to plastic and ‡ Cells were not irradiated.
by rosetting with sheep red blood cells, respectively, as previously described. 13 Immunoprecipitated proteins on PGS were washed three times with Enhancement of wild-type p53 protein expression by g-irradia-1 mL of lysis buffer and twice with 50 mmol/L HEPES (pH 7.5) tion. To enhance wild-type p53 protein expression, cells were irracontaining 1 mmol/L dithiothreitol and suspended in 30 mL of kinase diated (3.0 Gy) and lysed 2 hours later. Increased wild-type p53 buffer (50 mmol/L HEPES, 10 mmol/L MgCl 2 , 1 mmol/L dithiothreprotein expression was confirmed by immunoprecipitation and Westitol) containing substrate and 2.5 mmol/L EGTA, 10 mmol/L bern blotting, as described below. glycerophosphate, 0.1 mmol/L sodium orthovanadate, 1 mmol/L Cell cycle analysis. MM-derived cell lines (2 1 10 5 /mL) and NaF, 20 mmol/L ATP, and 10 mCi of g-32 P-ATP (NEN Dupont, patient MM cells (1 1 10 6 /mL) were cultured with media alone, Boston, MA). For CDK2 kinase assays, 1 mg of histone H1 (Boeh-Dex, IL-6, IFN-g, and Dex or IFN-g / IL-6. Cells were harvested ringer Mannheim, Indianapolis, IN) was the substrate; for CDK4 at intervals, washed with phosphate-buffered saline, stained with and CDK6 kinase assays, 1 mg of soluble glutathione S-transferase propidium iodide (PI), and analyzed using fluorescence-activated (GST)-RB fusion protein (Santa Cruz Biotechnology, Santa Cruz, cell sorting (FACS). 27 Specifically, cells were collected and resus-CA) was the substrate. After incubation for 30 minutes at 30ЊC with pended in 0.5 mL of 3.4 mmol/L sodium citrate, 10 mmol/L NaCl, occasional mixing, the samples were boiled in polyacrylamide gel 0.1% NP-40, and 50 mg/mL PI to stain nuclear DNA. Fluorescence sample buffer and separated by SDS electrophoresis. Phosphorylated intensity was measured using the Coulter Epics 753 Cell Sorter proteins were visualized by autoradiography of the dried slab gels. (Coulter Immunology, Hialeah, FL). For each sample, 10,000 cells
The intensity was quantitated with densitometry compared with mewere analyzed and results were processed using program M Cycle dia alone. software (Coulter).
Reagents. IL-6 (Kirin-Brewery Co Ltd, Tokyo, Japan) and/or Immunoprecipitation and Western immunoblotting. Immunopre-Dex (Sigma) or IFN-g (Endogen, Cambridge, MA) were added to cipitation and Western immunoblotting were performed as precultures of patient MM cells and MM-derived cell lines; the effects viously reported. 26 For immunoprecipitation, cells (1 1 10 7 cells/ on cell cycle distribution and kinetics of cell cycle protein expression sample) were cultured in 10% FBS-RPMI-1640 media or 10% FBSand association were assayed. Immunoprecipitation and Western im-Iscove's media, washed three times with phosphate-buffered saline, munoblotting were performed using mouse anti-p27 KIP1 (p27) and lysed for 30 minutes at 4ЊC in buffer: 50 mmol/L Tris-HCl (pH MoAb, anti-p21 MoAb, anti-pRB MoAb, or anti-actin MoAb (Onco-8.0), 150 mmol/L NaCl, 0.1% Nonidet P-40, 1 mmol/L EDTA, 5
gene Science, Uniondale, NY); with rabbit anti-p21, anti-p27, antimg/mL phenylmethyl sulfonyl fluoride, 1 mmol/L Na 3 VO 4 , 2 mg/ CDK2, anti-CDK4 (carboxy terminus), anti-CDK-6 (carboxy termi-mL aprotinin, 2 mg/mL leupeptin, and 50 mmol/L NaF. Antibodies nus), anti-cyclin D2, and anti-cyclin E (Santa Cruz Biotechnology) against cell cycle regulatory proteins were added and incubated for polyclonal Abs; and with mouse anti-cyclin E MoAb (Santa Cruz 16 hours at 4ЊC. Proteins were collected using protein G sepharose Biotechnology).
(PGS). Aliquots of each lysate were analyzed by sodium dodecyl
To detect wild-type and/or mutated p53 protein, cell lysates were sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Protein immunoprecipitated with Ab-5 anti-p53 MoAb, which recognizes was transferred onto nitrocellulose membranes, and nonspecific wild-type p53, or with Ab-3 anti-p53 MoAb, which recognizes mubinding was blocked by incubation with 5% skim milk. The memtated type p53, and then immunoblotted with Ab-6 anti-p53 MoAb branes were probed with antibodies, incubated with antimouse or (Oncogene Science) or DO-1 horseradish peroxidase-conjugated antirabbit Ig antibodies conjugated with horseradish peroxidase anti-p53 MoAb recognizing pantropic p53 (Santa Cruz Biotechnol-(Amersham, Arlington Heights, IL), and detected using the enhanced ogy). chemiluminescence system (Amersham).
Immune complex kinase assays. Immune complex kinase assays RESULTS were performed using the method of Matsushime et al, 29 with modi-
Expression of wild-type and mutated p53, as well as p21
fication. Briefly, cells were suspended at 1 1 10 7 /mL in the lysis and p27, in MM cell lines and patient MM cells. Expresbuffer described above and centrifuged at 10,000g for 5 minutes, sion of wild-type and mutated p53, as well as p21 and p27, in and the supernatants were precipitated for 16 hours at 4ЊC with PGS plus rabbit anti-CDK2, anti-CDK4, or anti-CDK6 polyclonal Abs. showed that all six MM cell lines expressed mutated p53 Dex in OCI-My5 and S6B45 cells, as well as in the cells of MM patients no. 1, 3, and 5. MM cell lines and MM patient protein. Specifically, RPMI-8226, U-266, and HS Sultan expressed mutated p53 protein, with loss of heterozygosity, cells were defined as IL-6 responsive if IL-6 shifted the fraction of MM cells from G1 to S by ¢10% and/or inhibited because wild-type p53 remained undetectable even after girradiation. p53 protein expression in these MM cell lines Dex-induced G1 growth arrest by ¢10%. Viability of all MM cell lines and patient MM cells remained high (ú95%) was consistent with a previous report of p53 gene using polymerase chain reaction single-stranded conformation during the 16 hours of culture with media, IL-6, Dex, or both. polymorphism analysis. 30 In contrast, three MM cell lines (OCI-My5, S6B45, and ARH-77) expressed both wild-type Total lysates were next made from five MM cell lines and five MM patient cells cultured under similar conditions. p21 and mutated p53 proteins. The JKB ALL cell line showed increased wild-type p53 protein expression induced by irra-was constitutively expressed in Dex-sensitive MM cell lines that were both responsive to IL-6 (OCI-My5, U-266, and diation, without detectable mutated p53.
MM cells is shown in
Two of five patients' MM cells expressed mutated p53 S6B45) and nonresponsive to IL-6 (HS Sultan and RPMI-8226), as well as in IL-6-nonresponsive JKB ALL cells protein, which was associated with loss of heterozygosity in a single case. The remaining three patient MM cells ex- (Fig 2A and B) . It was similarly constitutively expressed in both IL-6-responsive (patients no. 1, 3, and 5) and IL-6-pressed wild-type p53 protein, induced by irradiation, without detectable mutated p53 protein. Except for ARH-77 cells, nonresponsive (patients no. 2 and 3) patient MM cells ( Fig  2C and D) . In contrast, p21 was not detectable in ARH-77 p21 and p27 proteins were expressed in all MM cell lines and patient MM samples, including cells expressing wild-MM cells (Fig 2E) , normal B cells, or normal BMMCs ( Fig  2F) . IL-6 downregulated p21 protein expression in OCI-type and/or mutant p53. Finally, p27 protein expression was not altered by Dex and/ or IL-6 in these same cell lysates from either MM cell lines showed that IL-6 blocked the G1 growth arrest induced by or patient MM cells. cells cultured under the same conditions (Fig 3) . p21 protein * Cell lines (2 1 10 5 ) and patients' MM cells (1 1 10 6 ) were cultured was constitutively expressed and unchanged throughout 48 for 16 hours with media alone, IL-6 (50 ng/mL), Dex, or IL-6 (50 ng/ mL) / Dex (1 mmol/L).
Effects of Dex and/or IL-6 on cell cycle distribution and

Time-and dose-dependent effects of Dex and/or IL-6 on
hours of culture in media. Dex triggered peak increases in AID Blood 0001 / 5h38$$$$$1 06-02-97 12:57:32 bldal WBS: Blood p21 protein expresssion at 8 to 16 hours, which returned to also dependent on IL-6 dose. In contrast, levels of p27 protein expression in these same cell lysates were unchanged baseline at 48 hours. In the presence of IL-6, p21 protein expression decreased with time. Finally, culture with both in the presence of Dex and/or IL-6 and confirmed equal protein loading. Dex and IL-6 also decreased p21 expression, but to a lesser extent than noted in lysates from cells cultured with IL-6
Effects of Dex and/or IL-6 on expression of CDK2, CDK4, and CDK6; binding of p21 to CDK2, CDK4, and CDK6; alone.
The dose response of Dex and IL-6 effects on p21 expres-expression of cyclin E and D2; and phosphorylation of RB in OCI-My5 cells. The observations that Dex induced G1 sion was next examined, again using OCI-My5 MM cells. As can be seen in Fig 4, Dex (0.01 to 10 mmol/L) triggered growth arrest and that IL-6 facilitated entry from G1 to S phase in OCI-My5 MM cells, with corresponding changes a dose-dependent increase in p21 protein expression. Moreover, IL-6-related decreases in p21 protein expression were in p21 protein expression, prompted us to next examine ex-
Fig 2. Effects of Dex and/or IL-6 on p21 protein expression in MM cell lines and patient MM cells. Cells (2 Ì 10 5 /mL) from IL-6-responsive MM-derived cell lines (OCI-My5, S6B45, and U-266; A) and IL-6-nonresponsive MM cell lines (HS Sultan and RPMI-8226) and JKB ALL cell line (B); 1 Ì 10 6 /mL IL-6-responsive patient MM cells (patients no. 1, 3, and 5; C) and IL-6-nonresponsive patient MM cells (patients no. 2 and 4; D); 2 Ì 10 5 /mL IL-6-nonresponsive Dex-resistant ARH-77 MM cells (E); and 1 Ì 10 6 /mL normal BMMCs and splenic B cells (F) were cultured with 10% FBS media alone, IL-6 (50 ng/mL), Dex (1 mmol/L), or Dex (1 mmol/L) and IL-6 (50 ng/mL). Total cell lysates were prepared 16 hours later and immunoprecipitated with anti-p21 or anti-p27 polyclonal Abs, followed by Western immunoblotting with anti-p21 or anti-p27 MoAbs. Immunoprecipitation and immunoblotting with anti-actin MoAb confirmed equal protein loading in cells that lacked detectable p21 and p27: ARH-77 (E) and normal BMMCs and splenic B cells (F).
pression of other proteins (CDK2, CDK4, CDK6, cyclin D2, dia cultures, and their expression was unchanged in the presence of IL-6 and/or Dex. cyclin E, and pRB) known to regulate G1/S transition, as well as the binding of CDK2, CDK4, and CDK6 to p21 ( Fig  The binding of p21 to CDK2, CDK4, and CDK6 in these cell lysates was investigated using immunoprecipitation and 5). CDK2 was constitutively expressed in its dephosphorylated form in media cultures; phosphorylation was induced Western blotting ( Fig 5) . p21 was constitutively bound to CDK2, CDK4, and CDK6. This binding was decreased by by IL-6 and downregulated by Dex. Moreover, IL-6 inhibited the decrease in phosphorylation of CDK2 triggered by Dex. IL-6 and increased by Dex; in addition, IL-6 inhibited the upregulation in binding triggered by Dex. These changes CDK4 and CDK6 were also constitutively expressed in me- Table 3 Effects of Dex and/or IL-6 on CDK2, CDK4, and CDK6 protein kinase activities. Given the effects of Dex and/or IL-6 on binding of p21 to CDK2, CDK4, and CDK6 described above, we next examined effects of Dex and/or IL-6 on CDK2-, CDK4-, and CDK6-associated kinase activities in OCI-My5 MM cells (Fig 6) . Because p21 is known to induce dephosphorylation of pRB through suppression of CDK2-cyclin E complex as well as CDK4-cyclin D and CDK6-cyclin D complexes, cell lystates were immunoprecipitated with anti-CDK2, anti-CDK4, or anti-CDK6 antibodies; the CDK2-and CDK4 or CDK6-associated immune complexes were assayed for kinase activities by using histone H1 protein or purified GST-RB fusion protein substrates, respectively. Relative to cultures with media alone, IL-6 increased kinase activities of these complexes, as evidenced by phosphorylation of histone H1 or GST-RB fusion protein. In contrast, Dex inhibited activity of these kinases compared with media alone. IL-6 blocked the Dex-related downregulation of these kinase activities, corresponding to its affects on cell cycle distribution, p21 expression, and p21 binding to CDKs.
. Time-Dependent Effects of Dex and/or IL-6 on Cell Cycle Distribution of OCI-My5 Cells
Effects of IFN-g and/or IL-6 on cell cycle distribution and p21 protein expression in patient MM cells. Because IFNg suppresses the growth of epidermoid carcinoma cells by upregulating p21 transcription, 31 we studied the effects of IFN-g on cell cycle distribution (Table 4 ) and p21 protein expression (Fig 7) in the MM cells of patient no. 1. Cell cycle distribution did not significantly change during 48 hours of culture of the MM cells of patient no. 1 in media alone. As was noted above with Dex, IFN-g increased the percentage of cells in G1 (peak 10% increments at 16 hours). In contrast, IL-6 downregulated the fraction of cells in G1 and upregulated those in S by 5% to 10%. Finally, as was observed with Dex / IL-6, the cell cycle distribution in the presence of both IFN-g and IL-6 was similar to that noted in cultures with IL-6 alone.
The kinetics of p21 protein expression in the MM cells of patient no. 1 was next examined under the same culture conditions (Fig 7) . p21 protein expression in MM cells cultured in media alone was constant during the 48 hours of culture. IFN-g increased and IL-6 decreased p21 protein expression; p21 protein expression in the presence of both In the present study, we found p21 protein to be constitu-Western immunoblotting with anti-p21 MoAb.
tively expressed in the majority of MM cells and to be undetectable in normal B cells and BMMCs. This may appear counterintuitive because p21 inhibits cellular proliferation in both p53-dependent and -independent mechanisms. 32,33 How-parallelled changes in p21 protein expression in lysates from cells cultured under similar conditions (Fig 2) . ever, p21 protein is also highly expressed in other malignancies, including glioblastoma, acute myelogenous leukemia Cyclin E and cyclin D2 were constitutively expressed in OCI-My5 MM cells, and their expression was not altered (AML), and non-small-cell lung cancer. [34] [35] [36] Morevoer, p21 gene is rarely mutated or deleted in cancers, 37,38 and p21-by IL-6 and/or Dex (Fig 5) . Finally, both phosphorylated pRB (110 kD) and dephosphorylated pRB (105 kD) were deficient mice do not develop tumors at frequencies higher than their normal littermates. 39 Interestingly, ectopic p21 ex-observed in OCI-My5 MM cells cultured in media alone (Fig 5) . IL-6 increased phosphorylation of pRB, whereas pression has been shown to confer resistance to apoptosis 40 and patients whose AML cells overexpress p21 protein dem-Dex triggered dephosphorylation of pRB. IL-6 inhibited Dex-induced dephosphorylation of pRB.
onstrate chemotherapy resistance. 35 The constitutive p21 ex- AID Blood 0001 / 5h38$$0001 06-02-97 12:57:32 bldal WBS: Blood hypothesized to protect from p53-dependent apoptosis by induction of cell-cycle arrest and subsequent DNA repair. 41, 42 Moreover, other factors that induce apoptosis in a p53-independent mechanism, such as Dex at high doses, 43 may also induce p21 and related cell cycle arrest at lower doses. 23 Of interest, the expression of p27 protein in MM cells in our study was not related to p21 protein expression, suggesting that p21 and p27 may have different inducers or suppressors, even though they have high homology and similar function.
In the present report, we also demonstrated that both Dex and IFN-g inhibited, whereas IL-6 facilitated, cell cycle progression from G1 to S phase. Dex has previously been reported to induce growth arrest and induce apoptosis in MM cells 9 ; however, inhibition of cell proliferation by Dex occurs before induction of apoptosis, 44 and the dose of Dex required to inhibit cell proliferation is at least 10-fold less than that required to induce programmed cell death. 23 In our study, 0.1 to 1 mmol/L Dex suppressed growth, as evidenced by G1 growth arrest at 16 hours. IL-6 inhibited Dex-induced G1 growth arrest only in IL-6-responsive MM cells. Moreover, in this study, IFN-g showed effects on MM cells similar to Dex, namely induction of G1 growth arrest.
The effects on cell cycle of Dex and IL-6 were correlated with changes in p21 expression. Specifically, in our study, Dex upregulated, whereas IL-6 downregulated, p21 expression in MM cells in a time-and dose-dependent fashion. Upregulation of p21 was temporally associated with G1 growth arrest induced by Dex, whereas downregulation of p21 triggered by IL-6 corresponded with G1 to S transition. These changes occurred only in IL-6-responsive MM cell lines and patient cells. It is of great interest that IL-6 inhibited the effects of Dex and IFN-g on both cell cycle distribution and p21 expression in MM cells. Both IL-6 and Dex can regulate a variety of transcription factors, ie, via AP-1, 24, [45] [46] [47] and it is therefore possible that Dex and IL-6 may have opposing affects on gene transcription. Alternatively, Chin et al 31 have demonstrated a sis-inducible element (SIE) in the p21 promotor that is a binding site for STAT proteins. In fact, IFN-g has been shown to upregulate transcription of p21 gene, coupled with activation of STAT1, in epidermal and MM patient cells, we next characterized p21 function, first in immunoprecipitation and immunoblotting assays with other known cell cycle regulatory proteins and then by kinase activity assays. In our study, p21 was constitutively bound pression MM cells may therefore also result in resistance to to CDK2, CDK4, and CDK6 in MM cells; this binding was apoptosis and related slow clinical progression of disease upregulated by Dex and decreased by IL-6, reflecting and chemoresistance. changes in p21 protein. Increased expression of p21 protein Although p21 can be induced by p53, p21 protein expresinhibits cyclin D-CDK4, cyclin D-CDK6, and cyclin Esion in MM cells in this study was not related to the status CDK2 complexes and increases dephosphorylation of pRB, of p53. This finding is consistent with reports in other maligresulting in growth suppression. 26 In this study, Dex-related nancies that also show that overexpression of p21 is not increases in p21 in MM cells were associated with dephosrelated to the status of p53 34-36 and suggests the existence of alternative mechanisms for induction of p21. Indeed, p21 is phorylation of pRB and growth arrest; conversely, decreases Patient no. 1 MM cells (5 1 10 5 ) were cultured with 10% FBS RPMI-1640 media alone, IL-6, Dex, or IL-6 / Dex. Cells (1 1 10 6 ) were harvested at intervals, washed, stained with PI, and analyzed using FACS. Values are the percentage of cells in G1 phase.
in p21 were associated with phosphorylation of pRB and G1 to S phase transition. The changes in binding of p21 to CDK2, CDK4, and CDK6 triggered by Dex, as well as related dephosphorylation of pRB, were also blocked by IL-6.
To confirm the functional significance of Dex and/or IL-6-induced alterations in p21 on CDK2, CDK4, and CDK6, we measured kinase activities of p21-CDK2-cyclin E, p21-CDK4-cyclin D, and p21-CDK6-cyclin D immune complexes, which are known to affect phosphorylation of pRB. Activity of these kinases in the presence of IL-6 and/or Dex mirrored the results of immunoprecipitation and immunoblotting studies of p21 with CDK2, CDK4, and CDK6. Specifically, kinase activities of the immune complexes were upregulated by IL-6 and downregulated by Dex. Moreover, IL-6 overcame the downregulation of these kinases in the presence of Dex.
This study therefore demonstrates that changes in cell cycle distribution in MM cells triggered by Dex, IL-6, and IFN-g correlate with changes in p21 protein expression and implicate p21 in coupling of Dex-, IL-6-, and IFN-g-related signals to G1 cell cycle regulation in MM cells. Further studies of the function of p21 in tumor cells, as well as mechanisms regulating its expression, may not only enhance our understanding of mechanisms of cell cycle control in MM cells, but also suggest innovative therapies for MM that target p21.
